Recent Insights: Mesenchymal Stromal/Stem Cell Therapy for Acute Respiratory Distress Syndrome

F1000Research - United Kingdom
doi 10.12688/f1000research.8217.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

Mesenchymal Stem (Stromal) Cells for Treatment of Acute Respiratory Distress Syndrome

Lancet Respiratory Medicine,The
PulmonaryRespiratory Medicine
2015English

Current Status of Stem Cell Therapy for Sepsis and Acute Respiratory Distress Syndrome

2020English

Cell Therapy for the Treatment of Sepsis and Acute Respiratory Distress Syndrome

Annals of Translational Medicine
Medicine
2017English

Update on Acute Respiratory Distress Syndrome�s Pathology. Recent Insights Into in Vivo Alveolar Regeneration

Shortness of Breath
2014English

Hot New Therapy for Sepsis and the Acute Respiratory Distress Syndrome

Journal of Clinical Investigation
Medicine
2002English

Exogenous Surfactant Therapy for Pediatric Patients With Acute Respiratory Distress Syndrome

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1997English

Mesenchymal Stem Cell Therapy for Acute and Chronic Pancreatitis

Journal of Gastroenterology
Gastroenterology
2017English

Surfactant Treatment for Acute Respiratory Distress Syndrome

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1999English

A Stromal Cell-Derived Factor 1a Analogue Improves Endothelial Cell Function in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy